Micron Technology, Inc. vs BIO-TECHNE Corp — how do they compare? Micron Technology, Inc. trades at $977.57 (market cap $977.44B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: Micron Technology, Inc. is far larger — about 87.6× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays the higher dividend (0.45%). Which is the better fit depends on your goals.
| MU | TECH | |
|---|---|---|
Market Cap | $977.44B | $11.16B |
Sector | Technology | Health |
52-Week High | $1.21K | $72.12 |
52-Week Low | $104.88 | $43.31 |
Enterprise Value | $957.80B | $11.24B |
Dividend Yield | 0.06% | 0.45% |
Trailing returns across standard periods
Latest headlines on both assets
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →